Introduction to the Special Issue “Biological Efficacy of Natural and Chemically Modified Products against Oral Inflammatory Lesions”
Abstract
:1. Antiviral and Antibacterial Agents
2. Kampo Medicine and Constitutive Plant Extracts
3. Protection and Regeneration Mechanism
4. Application of Metabolomics and QSAR
References
- Asai, D.; Nakashima, H. Pathogenic Viruses Commonly Present in the Oral Cavity and Relevant Antiviral Compounds Derived from Natural Products. Medicines 2018, 5, 120. [Google Scholar] [CrossRef] [PubMed]
- Kanamoto, T.; Terakubo, S.; Nakashima, H. Antimicrobial Susceptibilities of Oral Isolates of Abiotrophia and Granulicatella According to the Consensus Guidelines for Fastidious Bacteria. Medicines 2018, 5, 129. [Google Scholar] [CrossRef] [PubMed]
- Shuji Watanabe, S.; Toyama, T.; Sato, T.; Suzuki, M.; Morozumi, A.; Sakagami, H.; Hamada, N. Kampo Therapies and the Use of Herbal Medicines in the Dentistry in Japan. Medicines 2019, 6, 34. [Google Scholar] [CrossRef] [PubMed]
- Sunagawa, M.; Yamaguchi, K.; Tsukada, M.; Ebihara, N.; Ikemoto, H.; Hisamitsu, T. Kampo (Traditional Japanese Herbal) Formulae for Treatment of Stomatitis and Oral Mucositis. Medicines 2018, 5, 130. [Google Scholar] [CrossRef] [PubMed]
- Hara, Y.; Shiratuchi, H.; Kaneko, T.; Sakagami, H. Search for Drugs Used in Hospitals to Treat Stomatitis. Medicines 2019, 6, 19. [Google Scholar] [CrossRef] [PubMed]
- Ara, T.; Nakatani, S.; Kobata, K.; Sogawa, N.; Sogawa, C. The Biological Efficacy of Natural Products against Acute and Chronic Inflammatory Diseases in the Oral Region. Medicines 2018, 5, 122. [Google Scholar] [CrossRef] [PubMed]
- Edo, Y.; Otaki, A.; Asano, K. Quercetin Enhances the Thioredoxin Production of Nasal Epithelial Cells In Vitro and In Vivo. Medicines 2018, 5, 124. [Google Scholar] [CrossRef] [PubMed]
- Moritani, N.H.; Hara, E.S.; Kubota, S. New Functions of Classical Compounds against Orofacial Inflammatory Lesions. Medicines 2018, 5, 118. [Google Scholar] [CrossRef] [PubMed]
- Sakagami, H.; Sugimoto, M.; Kanda, Y.; Murakami, Y.; Amano, O.; Saitoh, J.; Kochi, A. Changes in Metabolic Profiles of Human Oral Cells by Benzylidene Ascorbates and Eugenol. Medicines 2018, 5, 116. [Google Scholar] [CrossRef] [PubMed]
- Sakagami, H.; Watanabe, T.; Hoshino, T.; Suda, N.; Mori, K.; Yasui, T.; Yamauchi, N.; Kashiwagi, H.; Gomi, T.; Oizumi, T.; et al. Recent Progress of Basic Studies of Natural Products and Their Dental Application. Medicines 2019, 6, 4. [Google Scholar] [CrossRef] [PubMed]
- Nagai, J.; Imamura, M.; Sakagami, H.; Uesawa, Y. QSAR Prediction Model to Search for Compounds with Selective Cytotoxicity Against Oral Cell Cancer. Medicines 2019, 6, 45. [Google Scholar] [CrossRef] [PubMed]
Keyword B | Number of Cited References | |||||
---|---|---|---|---|---|---|
Keyword A | ||||||
Stomatitis | Herpes Stomatitis | Aphthous Stomatitis | Oral Inflammation | Periodontitis | Gingivitis | |
Total | 28,542 (100) | 1935 (100) | 3781 (100) | 35,354 (100) | 37,596 (100) | 13,902(100) |
Survey 1: Age-related citation rate | ||||||
Elderly | 7695 (27) | 349 (18) | 1081 (29) | 8677 (25) | 12,603 (34) | 3833 (28) |
Adult | 10,241 (36) | 599 (31) | 1712 (45) | 12,122 (34) | 17,833 (47) | 6092 (44) |
Young | 1142 (4) | 88 (5) | 243 (6) | 2413 (7) | 2603 (7) | 1026 (7) |
Child | 2990 (10) | 434 (22) | 655 (17) | 2708 (8) | 2339 (6) | 2239 (16) |
Pediatric | 920 (3) | 83 (4) | 235 (6) | 1449 (4) | 660 (2) | 403 (3) |
Survey 2: Etiology | ||||||
Virus infection | 6267 (22) | 1582 (82) | 670 (18) | 1437 (4) | 689 (2) | 650 (5) |
Bacterial infection | 1658 (6) | 174 (9) | 267 (7) | 4529 (13) | 3852 (10) | 1711 (12) |
Radiotherapy | 1521 (5) | 46 (2) | 54 (1) | 352 (1.0) | 210 (0.6) | 57 (0.4) |
Inflammation | 1181 (4) | 53 (3) | 164 (4) | N.D. | 5989 (16) | 2669 (19) |
Autoimmune diseases | 941 (3) | 82 (4) | 248 (7) | 1885 (5) | 709 (2) | 370 (3) |
Drug-induced | 546 (1.9) | 8 (0.4) | 22 (0.6) | 265 (0.7) | 53 (0.1) | 485 (3) |
Fungal infection | 1048 (4) | 186 (10) | 164 (4) | 735 (2) | 198 (0.5) | 214 (2) |
Immune suppression | 428 (1.5) | 55 (3) | 40 (1.1) | 603 (2) | 131 (0.4) | 98 (0.7) |
Stress | 267 (0.9) | 13 (0.7) | 92 (2) | 2361 (7) | 997 (3) | 227 (1.6) |
Nutritional deficiencies | 250 (0.9) | 9 (0.5) | 90 (2) | 1243 (4) | 110 (0.3) | 162 (1.2) |
Genetic background | 202 (0.7) | 4 (0.2) | 40 (1.1) | 240 (0.7) | 450 (1.2) | 47 (0.3) |
Reactive oxygen species | 119 (0.4) | 0 (0) | 19 (0.5) | 902 (3) | 24 (0.06) | 150 (1.1) |
Vitamin B deficiency | 107 (0.4) | 0 (0) | 52 (1.4) | 26 (0.1) | 2 (0.01) | 14 (0.1) |
Cigarette | 60 (0.2) | 9 (0.5) | 18 (0.5) | 250 (0.7) | 323 (0.9) | 82 (0.6) |
Dental prosthetics | 18 (0.06) | 0 (0) | 1 (0.03) | 19 (0.05) | 42 (0.1) | 14 (0.1) |
Survey 3: Treatment | ||||||
Antiviral agent | 3716 (13) | 579 (30) | 116 (3) | 1028 (3) | 321 (0.9) | 102 (0.7) |
Antibacterial agent | 2333 (8) | 86 (4) | 324 (9) | 3036 (9) | 2907 (8) | 660 (5) |
Anti-inflammatory agent | 1492 (5) | 66 (3) | 357 (9) | 4975 (14) | 1036 (3) | 474 (3) |
Steroid | 1234 (4) | 59 (3) | 319 (8) | 2761 (8) | 583 (2) | 342 (2) |
Natural product | 1105 (4) | 85 (4) | 120 (3) | 2063 (6) | 640 (2) | 314 (2) |
Trad. Chinese Med. | 54 (0.2) | 2 (0.1) | 24 (0.6) | 349 (1.0) | 45 (0.1) | 3 (0.02) |
Kampo medicine | 14 (0.05) | 0 (0) | 1 (0.03) | 27 (0.1) | 4 (0.01) | 2 (0.01) |
Anti-fungal agent | 1029 (4) | 48 (2) | 55 (1.5) | 674 (2) | 128 (0.3) | 37 (0.3) |
Immunopotentiator | 359 (1.2) | 40 (2) | 127 (3) | 723 (2) | 128 (0.3) | 37 (0.3) |
© 2019 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sakagami, H. Introduction to the Special Issue “Biological Efficacy of Natural and Chemically Modified Products against Oral Inflammatory Lesions”. Medicines 2019, 6, 52. https://doi.org/10.3390/medicines6020052
Sakagami H. Introduction to the Special Issue “Biological Efficacy of Natural and Chemically Modified Products against Oral Inflammatory Lesions”. Medicines. 2019; 6(2):52. https://doi.org/10.3390/medicines6020052
Chicago/Turabian StyleSakagami, Hiroshi. 2019. "Introduction to the Special Issue “Biological Efficacy of Natural and Chemically Modified Products against Oral Inflammatory Lesions”" Medicines 6, no. 2: 52. https://doi.org/10.3390/medicines6020052
APA StyleSakagami, H. (2019). Introduction to the Special Issue “Biological Efficacy of Natural and Chemically Modified Products against Oral Inflammatory Lesions”. Medicines, 6(2), 52. https://doi.org/10.3390/medicines6020052